Stock PBH PRESTIGE CONSUMER HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Prestige Consumer Healthcare Inc.

Equities

PBH

US74112D1019

Market Closed - Nyse
Other stock markets
 01:30:01 27/04/2024 am IST 		5-day change 1st Jan Change
70.47 USD +0.47% Intraday chart for Prestige Consumer Healthcare Inc. +1.15% +15.11%
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing MT
16/02 Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Adjusts Prestige Consumer Healthcare's Price Target to $71 From $72, Maintains Outperform Rating
MT
Canaccord Genuity Starts Prestige Consumer Healthcare at Buy With $71 Price Target
MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $63 From $68, Maintains Outperform Rating
MT
Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $68 From $63, Maintains Outperform Rating
MT
ANALYST RECOMMENDATIONS : Edison International, Ford, General Motors, GSK, Upstart...
Our Logo
Jefferies Upgrades Prestige Consumer Healthcare to Buy From Hold, Adjusts Price Target to $70 From $65
MT
DA Davidson Lowers Prestige Consumer Healthcare's Price Target to $60 From $63, Maintains Neutral Rating
MT
Oppenheimer Upgrades Prestige Consumer Healthcare to Outperform From Perform, Sets $63 Price Target
MT
DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps Neutral Rating
MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $61 from $52, Keeps Neutral Rating
MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $52 from $49, Keeps Neutral Rating
MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $49 from $39, Keeps Neutral Rating
MT
PRESTIGE CONSUMER HEALTHCARE : DA Davidson Adjusts Prestige Consumer Healthcare's Price Target to $39 from $45, Maintains Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PBH Stock
  4. News Prestige Consumer Healthcare Inc.
  5. Analyst Reco.